Loading candles…
Anlon Healthcare Limited, incorporated in 2013 and headquartered in Rajkot, Gujarat, is a chemical manufacturing company specializing in the production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Operating in the chemical manufacturing and pharmaceutical industries within India, it focuses on APIs that serve as raw materials for finished dosage pharmaceutical formulations. The company manufactures specific APIs including Loxoprofen Sodium Dihydrate, Ketoprofen, and Dexketoprofen Trometamol, which are primarily used in medications for pain and inflammation management. Anlon Healthcare Limited is among the few Indian manufacturers of these particular APIs.
This page is a live market overview for ANLON HEALTHCARE LIMITED (AHCL) on the NSE. As a listed security, ANLON HEALTHCARE LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AHCL before placing trades on tick2trade.
As of the latest feed, AHCL last traded at ₹14.55 on NSE, up ₹0.34 (2.39%) from the previous close of ₹14.21. Today's session range is ₹13.97 – ₹14.7, against a 52-week band of ₹9.08 – ₹17.28. Traded volume today stands at 32.03L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for AHCL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AHCL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ANLON HEALTHCARE LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AHCL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AHCL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Other | To consider other business matters | 11 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 30 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and and other business matters. | 29 May 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.